–
New Buy Entry Alert MSB
Time Frame : Daily/Weekly
Sector : Pharmaceuticals, Biotech and Life Sciences/Healthcare
Key Stats : $971.39 Million Market Cap, VWAP 1.87, ASX Ranking 258, 4 Week Av Turnover $3,549,589, Current Turnover (Intraday as at time of alert) $1,268,957 (as at 10:52am).
Company Overview : Mesoblast Limited (MSB) is an Australian company engaging in the development of biologic products for regenerative medicine. The key focus is on research and development of adult Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp cells and Adipose cells. Its intellectual property covers applications in key markets including the United States, Europe, Japan and China.
Broker Consensus : BUY
–
MSB – Mesoblast Limited
MSB is set to break to new highs after some time spent consolidating a major higher low. We are now happy to buy on a push up through 1.92 with a Stop Loss at 1.76. If price falls below 1.76 prior to entry, we will cancel the alert and re-assess the action.
–
Stock Code : MSB – Mesoblast Limited
Company Website : www.mesoblast.com
Current Price : 1.885
New Potential Buy Entry (Trigger Level) : 1.92
Potential Sell Exit Zone (Stop Loss/Cancel Level) : 1.76
Status : On watch for Buy Entry Trigger
